FDA
-
-
-
-
-
-
-
JAMA publishes positive LSD study results for anxiety treatment
-
-
-
-
-
-
-
MindMed Appoints Matt Wiley as Chief Commercial Officer
-
-
-
-
-
-
-
Mind Medicine (MNMD) Awarded Innovation Passport Designation by the United Kingdom (UK) Innovative Licensing and Access Pathway (ILAP) Steering Group for MM120 Orally Disintegrating Tablet (ODT) for G
-
-
-
-
-
-
-
MindMed Reports Second Quarter 2024 Financial Results and Business Updates
-
-
-
-
-
-
-
Baird Reiterates Outperform Rating on MindMed (MNMD)
-
-
-
-
-
-
-
MindMed Receives FDA Breakthrough Therapy Designation and Announces Positive 12-Week Durability Data From Phase 2B Study of MM120 for Generalized Anxiety Disorder
-
-
-
-
-
-
-
FCM Denounces MindMed’s Manipulation of Corporate Machinery to Protect Incumbent Board of Directors
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

